Aptevo Therapeutics Inc (APVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,161 | -12,612 | -6,408 | -24,130 | -17,818 |
| Depreciation Amortization | 159 | 110 | 61 | 352 | 281 |
| Accounts payable and accrued liabilities | -591 | -1,315 | -814 | -1,017 | -1,341 |
| Other Working Capital | -448 | -1,183 | -408 | -1,076 | -1,630 |
| Other Operating Activity | 685 | 1,332 | 994 | 2,086 | 2,482 |
| Operating Cash Flow | $-20,356 | $-13,668 | $-6,575 | $-23,785 | $-18,026 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 32,703 | 14,364 | N/A | 15,599 | 8,879 |
| Other Financing Activity | 0 | 0 | 0 | -4 | -4 |
| Financing Cash Flow | $32,703 | $14,364 | $N/A | $15,595 | $8,875 |
| Beginning Cash Position | 8,714 | 8,714 | 8,714 | 16,904 | 16,904 |
| End Cash Position | 21,061 | 9,410 | 2,139 | 8,714 | 7,753 |
| Net Cash Flow | $12,347 | $696 | $-6,575 | $-8,190 | $-9,151 |
| Free Cash Flow | |||||
| Operating Cash Flow | -20,356 | -13,668 | -6,575 | -23,785 | -18,026 |
| Free Cash Flow | -20,356 | -13,668 | -6,575 | -23,785 | -18,026 |